Cognitive Behavioral Therapy for Insomnia to Address Insomnia Symptoms in People With Multiple Sclerosis
NCT ID: NCT03216889
Last Updated: 2019-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
43 participants
INTERVENTIONAL
2017-06-29
2019-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis
NCT06428006
Feasibility of Web-based CBT-I Intervention in Individuals With Multiple Sclerosis
NCT03783585
Digital Cognitive-behavioral Therapy for Insomnia for Patients With Multiple Sclerosis
NCT06025968
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
NCT04147052
Sleep and Pain Intervention for Chronic Widespread Pain Pilot Study
NCT02688569
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive Behavioral Therapy for Insomnia (CBT-I)
6 weeks of CBT-I.
Cognitive Behavioral Therapy for Insomnia
Involves attending 1 hour long sessions weekly for 6 weeks. Sessions will be one-on-one or in a group.
Control
6 weeks of stretching and thinking games.
Control
Involves attending 1 hour long sessions weekly for 6 weeks. Sessions will involve stretching and thinking games.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Behavioral Therapy for Insomnia
Involves attending 1 hour long sessions weekly for 6 weeks. Sessions will be one-on-one or in a group.
Control
Involves attending 1 hour long sessions weekly for 6 weeks. Sessions will involve stretching and thinking games.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Report of difficulty falling asleep, maintaining sleep, or waking up too early at least 3 nights/week for the past 6 months,
* ≥10 on Insomnia Severity Index
* English speaking
* Core at least 24 on the Mini-Mental State Exam (MMSE) to indicate reduced risk of dementia
Exclusion Criteria
* \>4 on STOP BANG indicating high risk of sleep apnea
* Increased risk of restless leg syndrome on Restless Legs Syndrome (RLS) Diagnosis Index
* Nervous system disorder other than MS
* Relapse and/or corticosteroid use in past 8 weeks
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Multiple Sclerosis Society
OTHER
University of Kansas Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katie Siengsukon, PT, PhD
Role: STUDY_CHAIR
University of Kansas Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Kansas Medical Center
Kansas City, Kansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00140418
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.